IPN, Delhi, India. Open 10-6pm

+91 9891296838 / 9811747774

Lifyorli (relacorilant) capsules

Food and Drug Administration approved relacorilant (Lifyorli, Corcept Therapeutics Inc.), a glucocorticoid receptor antagonist, in combination with nab-paclitaxel for the treatment of adults with platinum-resistant epithelial ovarian, fallopian tube, or primary peritoneal cancer who have received one to three prior systemic treatment regimens, at least one of which included bevacizumab. Under the CDSCO Named Patient Program, Indian patients can legally import breast cancer drugs that are FDA-approved in other countries but not commercially marketed in India.

Brand Name: Lifyorli
Generic Name: relacorilant capsules
Strength: Capsules: 100 mg / 25 mg
Manufacturer: Corcept Therapeutics Incorporated
Approved By: EMA, USFDA

Source Details: Patient Information.

Get access Lifyorli for ovarian cancer Treatment through Named-Patient Import in India

IPN, New Delhi serves as a facilitator for the procurement of specialized drugs on behalf of patients or treating doctors, enabling access to Lifyorli (relacorilant) for personal use. For any queries, including information regarding the cost of the pharmaceutical product in India, please contact the IPN Healthcare Support Team via email or at the following numbers: Mobile/WhatsApp: Mr. Tarun: +91 9891 296 838 |  Mr. Neeraj: +91 9811 747 774.

Categories: ,

Contact Info

CORPORATE OFFICE:

Basement-B-5-A, Ajit Singh House Building No.12, Yusuf Sarai, South Delhi,
New Delhi:110016 India.

MOBILE / PHONE NUMBER:

M: +91 9811747774, 9891296838.
P / F: +91-11-26532129 / 26536398

EMAIL ID:

info@indianpharmanetwork.co.in

    Relacorilant, sold under the brand name Lifyorli, is an anti-cancer medication used for the treatment of ovarian cancer, fallopian tube cancer, or primary peritoneal cancer. Relacorilant is a glucocorticoid receptor antagonist. The most common adverse reactions include decreased hemoglobin, decreased neutrophils, fatigue, nausea, diarrhea, decreased platelets, rash, and decreased appetite.

    LIFYORLI is an oral medication designed to help your chemotherapy work better. By inhibiting cortisol activity in cancer and immune cells, it makes nab-paclitaxel, a chemotherapy, more effective and may indirectly activate your immune system. This helps support your immune system in fighting the cancer.

    Is Lifyorli (relacorilant) available in India?

    Lifyorli (relacorilant) may be accessed in India through a named-patient import process with a valid doctor’s prescription, and Indian Pharma Network (IPN), New Delhi, assists with compliant sourcing and delivery of specialty medicines subject to regulatory approvals.

    How to get Lifyorli Capsules delivered in India?

    Indian Pharma Network (IPN), based in New Delhi, helps patients and healthcare providers with the sourcing and import coordination of specialty medicines in compliance with applicable Indian regulations. Availability, import eligibility, pricing, and delivery timelines may vary and are subject to regulatory approvals and documentation requirements.

    IPN having representation in Delhi, Gurugram, Mumbai, Bengaluru, Kolkata, Chennai, Pune, Ahmedabad, Hyderabad, Chandigarh, Jaipur, and Lucknow.

    Who can help source Lifyorli Capsules in India legally?

    Named-patient import facilitator contact details
    Company Name: Indian Pharma Network (IPN)
    Address: 60/4 1st Floor, T&T Building, Indian Oil Complex, Yusuf Sarai, Delhi 110016
    For sourcing and import coordination of specialty medicines, contact:
    Mr. Tarun: +91 9891 296 838
    Mr. Neeraj: +91 9811 747 774
    Email: info@indianpharmanetwork.co.in

    Patients are advised to independently verify the credentials, licensing, and regulatory compliance of any facilitator before proceeding.

    Note:
    We are the facilitator, group of highly qualified healthcare professionals, provide solutions on how to get access of anti cancer medicines not available in India. On the basis of permission in Form 12B (Import permit) from From Ministry of Health, Government of India, IPN, New Delhi procure drugs on behalf of patient. Indian Pharma Network (IPN) serves as a legitimate consultant and facilitator situated in New Delhi, India. With over two decades of industry experience, IPN offers extensive coverage across India.

    Indian Pharma Network (IPN), New Delhi. India

    Indian Pharma Network (IPN) is registered organisation in India, having highly qualified healthcare professionals of pharmaceutical Industry. Specialized in Oncology Products. Helped more than 6,000 patients. Registration Number : 07AAFFI2544E1ZO under GST Act.
    Branch Offices in India : New Delhi | Bengaluru | Kolkata | Lucknow | Jaipur | Jodhpur.
    Our Overseas Network UK | Russia | Brazil | Mexico | Germany | France| Italy | Spain | Japan | China| Australia | Brazil | Saudi Arabia | South Africa

    Indian Pharma Network
    60/4 1st Floor, T&T Building, Indian Oil Complex, Yusuf Sarai, Delhi 110016

    Mobile / WhatsApp / Phone
    M: +91 9811747774, 9891296838.
    P: +91-11-26532129 / 26536398